The future of GLP-1 research As GLP-1s continue to reshape the treatment of type 2 diabetes and obesity (along with an expanding list of potential indications), real-world evidence will be essential for optimizing their use, ensuring access, and tailoring treatments to the individual needs of patients
Despite label updates over time for other safety concerns, including ileus and risks associated with anesthesia, the lawsuit alleges that Novo Nordisk failed to disclose the risk of NAION
Some early research suggests that semaglutide may be associated with a lower likelihood of developing cannabis use disorder compared with other medications, though this observational finding does not prove causation, and more clinical studies are needed
Clin Endocrinol (2013) 79(4):58490
Mix in your cleansing milk Only logged in customers who have purchased this product may leave a review
Understanding these interactions and contraindications helps ensure safety when using these medications